$37.7
Baxter International is a medical instruments & supplies business based in the US. Baxter International shares (BAX) are listed on the NYSE and all prices are listed in US Dollars. Baxter International employs 60,000 staff and has a trailing 12-month revenue of around $15.2 billion.
How to buy Baxter International stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – BAX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
eToro
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
tastytrade
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
What's in this guide?
Baxter International stock price (NYSE: BAX)
Use our graph to track the performance of BAX stocks over time.Baxter International shares at a glance
Latest market close | $37.70 |
---|---|
52-week range | $36.82 - $56.72 |
50-day moving average | $43.25 |
200-day moving average | $44.03 |
Wall St. target price | $50.42 |
PE ratio | N/A |
Dividend yield | $1.16 (3%) |
Earnings per share (TTM) | $-5.59 |
Buy Baxter International stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Baxter International stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Baxter International price performance over time
Historical closes compared with the close of $37.7 from 2023-09-22
1 week (2023-09-18) | -2.66% |
---|---|
1 month (2023-08-25) | -9.22% |
3 months (2023-06-23) | -16.30% |
6 months (2023-03-24) | -3.90% |
1 year (2022-09-23) | -31.96% |
---|---|
2 years (2021-09-21) | N/A |
3 years (2020-09-25) | 78.5806 |
5 years (2018-09-25) | 74.805 |
Is Baxter International stock undervalued or overvalued?
Valuing Baxter International stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Baxter International's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Baxter International financials
Revenue TTM | $15.2 billion |
---|---|
Operating margin TTM | 11.65% |
Gross profit TTM | $6 billion |
Return on assets TTM | 3.7% |
Return on equity TTM | -38.63% |
Profit margin | -18.79% |
Book value | $11.00 |
Market Capitalization | $19.6 billion |
TTM: trailing 12 months
Baxter International share dividends
Dividend payout ratio: 40.85% of net profits
Recently Baxter International has paid out, on average, around 40.85% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Baxter International shareholders could enjoy a 3% return on their shares, in the form of dividend payments. In Baxter International's case, that would currently equate to about $1.16 per share.
While Baxter International's payout ratio might seem fairly standard, it's worth remembering that Baxter International may be investing much of the rest of its net profits in future growth.
Baxter International's most recent dividend payout was on 1 October 2023. The latest dividend was paid out to all shareholders who bought their shares by 30 August 2023 (the "ex-dividend date").
Have Baxter International's shares ever split?
Baxter International's shares were split on a 1841:1000 basis on 30 June 2015. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1841 shares. This wouldn't directly have changed the overall worth of your Baxter International shares – just the quantity. However, indirectly, the new 45.7% lower share price could have impacted the market appetite for Baxter International shares which in turn could have impacted Baxter International's share price.
Baxter International share price volatility
Over the last 12 months, Baxter International's shares have ranged in value from as little as $36.8228 up to $56.7173. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Baxter International's is 0.6124. This would suggest that Baxter International's shares are less volatile than average (for this exchange).
Baxter International overview
Baxter International Inc. , through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries.
Baxter International in the news

Baxter to Host Third-Quarter 2023 Financial Results Conference Call for Investors
Reasons to Retain Baxter International (BAX) in Your Portfolio
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Baxter International Inc. (BAX) Investors of a Class Action Lawsuit and Upcoming Deadline
Frequently asked questions
What percentage of Baxter International is owned by insiders or institutions?Currently 0.272% of Baxter International shares are held by insiders and 89.076% by institutions. How many people work for Baxter International?
Latest data suggests 60,000 work at Baxter International. When does the fiscal year end for Baxter International?
Baxter International's fiscal year ends in December. Where is Baxter International based?
Baxter International's address is: One Baxter Parkway, Deerfield, IL, United States, 60015 What is Baxter International's ISIN number?
Baxter International's international securities identification number is: US0718131099 What is Baxter International's CUSIP number?
Baxter International's Committee on Uniform Securities Identification Procedures number is: 071813141
More guides on Finder
-
How to buy Discord stock when it goes public
Everything we know about the Discord IPO, plus information on how to buy in.
-
Today’s trending Reddit stocks
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
-
How to buy Tottenham Acquisition I stock
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
-
How to buy TotalEnergies stock
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
-
How to buy Thunder Bridge Acquisition stock
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
-
How to buy Switchback Energy Acquisition Corporation stock
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
-
How to buy Telefonica SA ADR stock
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
-
How to buy Faraday Future stock
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
-
How to buy Phoenix Tree stock
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
-
How to buy Innate Pharma stock
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.
Ask an Expert